顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > フローサイトメトリー検査技術サービスの世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

フローサイトメトリー検査技術サービスの世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

Flow Cytometry Testing Technology Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
  • レポートID：
    203331
  • 発表時期：
    2026-02-11
  • レポート形式：
    PDF
  • 産業カテゴリー：
    ソフト及び商業サービス
  • レポート言語：
    英語、日本語
  • ページ数：
    136
  • 発行会社（調査会社）：
    QYResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=158.00円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界のフローサイトメトリー検査技術サービス市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。売上高に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からフローサイトメトリー検査技術サービス市場を分析し、需要構造と成長特性を明確化します。
フローサイトメトリー検査技術サービス市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、フローサイトメトリー検査技術サービスに関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要フローサイトメトリー検査技術サービス市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートはフローサイトメトリー検査技術サービス市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
フローサイトメトリー検査技術サービス市場の主要企業には以下が含まれます：
Bioss
Q2 Solutions
KMD Bioscience
Thermo Fisher Scientific Inc
BD
Creative Bioarray
Labcorp
RayBiotech
Sysmex Corporation
Abace Biotechnology
Multi Sciences (Lianke) Biotech Co., Ltd
Shanghai Yingbai Biotechnology Co., Ltd
COBIOER BIOSCIENCES CO.,LTD
Shanghai Medicilon Inc
Beijing Nuowei Biotechnology Co., Ltd
Wuhan Servicebio Technology Co., Ltd 

製品別
Analytical
Sorting Type 

アプリケーション別
Cell Cycle and Apoptosis Analysis
Immunological Analysis
Cell Typing Analysis
Other Fluorescence-Based Cytology Assays 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他
レポート構成（章別概要）
第1章｜市場概要と成長展望
フローサイトメトリー検査技術サービス市場の全体像を整理し、市場規模、売上予測を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
フローサイトメトリー検査技術サービス市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別にフローサイトメトリー検査技術サービス市場を分類し、売上高、市場シェアを分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別にフローサイトメトリー検査技術サービス市場規模、売上高、市場シェアを整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、売上高を詳細に分析し、フローサイトメトリー検査技術サービス市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します。
第6章｜国別市場動向
主要国・地域ごとに、フローサイトメトリー検査技術サービス市場の売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
フローサイトメトリー検査技術サービス市場を牽引する主要企業について、売上高、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
●フローサイトメトリー検査技術サービス市場の全体像と成長見通し
フローサイトメトリー検査技術サービス市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がフローサイトメトリー検査技術サービス市場に与える影響を分析いたします。
●市場環境の構成要素とマクロトレンド
フローサイトメトリー検査技術サービス産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します。
●競争構造と主要企業の動向分析
フローサイトメトリー検査技術サービス市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します。
●競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からフローサイトメトリー検査技術サービス市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします。
●成長要因・課題・リスクの分析
フローサイトメトリー検査技術サービス市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します。
●将来トレンドと市場展望
フローサイトメトリー検査技術サービス市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします。
title

Description

The global market for Flow Cytometry Testing Technology Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Flow cytometry testing technology services is a technology that measures the biological, physical and chemical characteristics of individual cells or organelles in a liquid system, and quantitatively analyzes and sorts the required cells or organelles according to these characteristics. It is a technology that can detect various characteristics of cells or biological particles, used to understand the mean and distribution of cell populations, and can also sort cells of interest for further culture research on the cells.
Flow Cytometry (FCM) is a high-tech technology developed in the 1970s. It is a modern cell analysis technology that can detect multiple parameters of a single particle quickly, accurately and objectively. It integrates computer technology, laser technology, fluid mechanics, cytochemistry, and cellular immunology, and has the function of analyzing and sorting cells. It can not only measure the characteristics of cell size and internal particles, but also detect cell surface and cytoplasmic antigens, intracellular DNA, RNA content, etc. It is widely used in hematology, immunology, oncology, pharmacology, molecular biology, and other disciplines.

This report provides a comprehensive view of the global market for Flow Cytometry Testing Technology Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Flow Cytometry Testing Technology Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Flow Cytometry Testing Technology Service.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Flow Cytometry Testing Technology Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Flow Cytometry Testing Technology Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Flow Cytometry Testing Technology Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
title

Table of Contents

1 Market Overview
    1.1 Flow Cytometry Testing Technology Service Product Introduction
    1.2 Global Flow Cytometry Testing Technology Service Market Size Forecast (2021–2032)
    1.3 Flow Cytometry Testing Technology Service Market Trends & Drivers
        1.3.1 Flow Cytometry Testing Technology Service Industry Trends
        1.3.2 Flow Cytometry Testing Technology Service Market Drivers & Opportunities
        1.3.3 Flow Cytometry Testing Technology Service Market Challenges
        1.3.4 Flow Cytometry Testing Technology Service Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Flow Cytometry Testing Technology Service Players Revenue Ranking (2025)
    2.2 Global Flow Cytometry Testing Technology Service Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Flow Cytometry Testing Technology Service Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Flow Cytometry Testing Technology Service
    2.6 Flow Cytometry Testing Technology Service Market Competitive Analysis
        2.6.1 Flow Cytometry Testing Technology Service Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Flow Cytometry Testing Technology Service Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Flow Cytometry Testing Technology Service revenue, 2025
    2.7 Mergers & Acquisitions and Expansion
3 Segmentation Flow Cytometry Testing Technology Service Market Classification
    3.1 Introduction by Type
        3.1.1 Analytical
        3.1.2 Sorting Type
        3.1.3 Global Flow Cytometry Testing Technology Service Sales Value by Type
            3.1.3.1 Global Flow Cytometry Testing Technology Service Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global Flow Cytometry Testing Technology Service Sales Value, by Type (2021–2032)
            3.1.3.3 Global Flow Cytometry Testing Technology Service Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Cell Cycle and Apoptosis Analysis
        4.1.2 Immunological Analysis
        4.1.3 Cell Typing Analysis
        4.1.4 Other Fluorescence-Based Cytology Assays
    4.2 Global Flow Cytometry Testing Technology Service Sales Value by Application
        4.2.1 Global Flow Cytometry Testing Technology Service Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Flow Cytometry Testing Technology Service Sales Value by Application (2021–2032)
        4.2.3 Global Flow Cytometry Testing Technology Service Sales Value by Application (%), 2021–2032
5 Segmentation by Region
    5.1 Global Flow Cytometry Testing Technology Service Sales Value by Region
        5.1.1 Global Flow Cytometry Testing Technology Service Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Flow Cytometry Testing Technology Service Sales Value by Region (2021–2026)
        5.1.3 Global Flow Cytometry Testing Technology Service Sales Value by Region (2027–2032)
        5.1.4 Global Flow Cytometry Testing Technology Service Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        5.2.2 North America Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        5.3.2 Europe Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        5.4.2 Asia Pacific Flow Cytometry Testing Technology Service Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        5.5.2 South America Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        5.6.2 Middle East & Africa Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.3.2 United States Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.4.2 Europe Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.5.2 China Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.6.2 Japan Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.7.2 South Korea Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.8.2 Southeast Asia Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Flow Cytometry Testing Technology Service Sales Value, 2021–2032
        6.9.2 India Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Flow Cytometry Testing Technology Service Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 Bioss
        7.1.1 Bioss Profile
        7.1.2 Bioss Main Business
        7.1.3 Bioss Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.1.4 Bioss Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.1.5 Bioss Recent Developments
    7.2 Q2 Solutions
        7.2.1 Q2 Solutions Profile
        7.2.2 Q2 Solutions Main Business
        7.2.3 Q2 Solutions Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.2.4 Q2 Solutions Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.2.5 Q2 Solutions Recent Developments
    7.3 KMD Bioscience
        7.3.1 KMD Bioscience Profile
        7.3.2 KMD Bioscience Main Business
        7.3.3 KMD Bioscience Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.3.4 KMD Bioscience Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.3.5 KMD Bioscience Recent Developments
    7.4 Thermo Fisher Scientific Inc
        7.4.1 Thermo Fisher Scientific Inc Profile
        7.4.2 Thermo Fisher Scientific Inc Main Business
        7.4.3 Thermo Fisher Scientific Inc Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.4.4 Thermo Fisher Scientific Inc Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.4.5 Thermo Fisher Scientific Inc Recent Developments
    7.5 BD
        7.5.1 BD Profile
        7.5.2 BD Main Business
        7.5.3 BD Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.5.4 BD Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.5.5 BD Recent Developments
    7.6 Creative Bioarray
        7.6.1 Creative Bioarray Profile
        7.6.2 Creative Bioarray Main Business
        7.6.3 Creative Bioarray Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.6.4 Creative Bioarray Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.6.5 Creative Bioarray Recent Developments
    7.7 Labcorp
        7.7.1 Labcorp Profile
        7.7.2 Labcorp Main Business
        7.7.3 Labcorp Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.7.4 Labcorp Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.7.5 Labcorp Recent Developments
    7.8 RayBiotech
        7.8.1 RayBiotech Profile
        7.8.2 RayBiotech Main Business
        7.8.3 RayBiotech Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.8.4 RayBiotech Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.8.5 RayBiotech Recent Developments
    7.9 Sysmex Corporation
        7.9.1 Sysmex Corporation Profile
        7.9.2 Sysmex Corporation Main Business
        7.9.3 Sysmex Corporation Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.9.4 Sysmex Corporation Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.9.5 Sysmex Corporation Recent Developments
    7.10 Abace Biotechnology
        7.10.1 Abace Biotechnology Profile
        7.10.2 Abace Biotechnology Main Business
        7.10.3 Abace Biotechnology Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.10.4 Abace Biotechnology Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.10.5 Abace Biotechnology Recent Developments
    7.11 Multi Sciences (Lianke) Biotech Co., Ltd
        7.11.1 Multi Sciences (Lianke) Biotech Co., Ltd Profile
        7.11.2 Multi Sciences (Lianke) Biotech Co., Ltd Main Business
        7.11.3 Multi Sciences (Lianke) Biotech Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.11.4 Multi Sciences (Lianke) Biotech Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.11.5 Multi Sciences (Lianke) Biotech Co., Ltd Recent Developments
    7.12 Shanghai Yingbai Biotechnology Co., Ltd
        7.12.1 Shanghai Yingbai Biotechnology Co., Ltd Profile
        7.12.2 Shanghai Yingbai Biotechnology Co., Ltd Main Business
        7.12.3 Shanghai Yingbai Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.12.4 Shanghai Yingbai Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.12.5 Shanghai Yingbai Biotechnology Co., Ltd Recent Developments
    7.13 COBIOER BIOSCIENCES CO.,LTD
        7.13.1 COBIOER BIOSCIENCES CO.,LTD Profile
        7.13.2 COBIOER BIOSCIENCES CO.,LTD Main Business
        7.13.3 COBIOER BIOSCIENCES CO.,LTD Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.13.4 COBIOER BIOSCIENCES CO.,LTD Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.13.5 COBIOER BIOSCIENCES CO.,LTD Recent Developments
    7.14 Shanghai Medicilon Inc
        7.14.1 Shanghai Medicilon Inc Profile
        7.14.2 Shanghai Medicilon Inc Main Business
        7.14.3 Shanghai Medicilon Inc Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.14.4 Shanghai Medicilon Inc Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.14.5 Shanghai Medicilon Inc Recent Developments
    7.15 Beijing Nuowei Biotechnology Co., Ltd
        7.15.1 Beijing Nuowei Biotechnology Co., Ltd Profile
        7.15.2 Beijing Nuowei Biotechnology Co., Ltd Main Business
        7.15.3 Beijing Nuowei Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.15.4 Beijing Nuowei Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.15.5 Beijing Nuowei Biotechnology Co., Ltd Recent Developments
    7.16 Wuhan Servicebio Technology Co., Ltd
        7.16.1 Wuhan Servicebio Technology Co., Ltd Profile
        7.16.2 Wuhan Servicebio Technology Co., Ltd Main Business
        7.16.3 Wuhan Servicebio Technology Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
        7.16.4 Wuhan Servicebio Technology Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million), 2021–2026
        7.16.5 Wuhan Servicebio Technology Co., Ltd Recent Developments
8 Industry Chain Analysis
    8.1 Flow Cytometry Testing Technology Service Value Chain
    8.2 Flow Cytometry Testing Technology Service Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Flow Cytometry Testing Technology Service Sales Model
        8.5.2 Sales Channels
        8.5.3 Flow Cytometry Testing Technology Service Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Flow Cytometry Testing Technology Service Market Trends
 Table 2. Flow Cytometry Testing Technology Service Market Drivers & Opportunities
 Table 3. Flow Cytometry Testing Technology Service Market Challenges
 Table 4. Flow Cytometry Testing Technology Service Market Restraints
 Table 5. Global Flow Cytometry Testing Technology Service Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Flow Cytometry Testing Technology Service Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Flow Cytometry Testing Technology Service Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Flow Cytometry Testing Technology Service
 Table 10. Global Flow Cytometry Testing Technology Service Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Flow Cytometry Testing Technology Service revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Flow Cytometry Testing Technology Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Flow Cytometry Testing Technology Service Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Flow Cytometry Testing Technology Service Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Flow Cytometry Testing Technology Service Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Flow Cytometry Testing Technology Service Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Flow Cytometry Testing Technology Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Flow Cytometry Testing Technology Service Sales Value by Application (US$ Million), 2021–2026
 Table 20. Global Flow Cytometry Testing Technology Service Sales Value by Application (US$ Million), 2027–2032
 Table 21. Global Flow Cytometry Testing Technology Service Sales Market Share in Value by Application (2021–2026)
 Table 22. Global Flow Cytometry Testing Technology Service Sales Market Share in Value by Application (2027–2032)
 Table 23. Global Flow Cytometry Testing Technology Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 24. Global Flow Cytometry Testing Technology Service Sales Value by Region (US$ Million), 2021–2026
 Table 25. Global Flow Cytometry Testing Technology Service Sales Value by Region (US$ Million), 2027–2032
 Table 26. Global Flow Cytometry Testing Technology Service Sales Value by Region (%), 2021–2026
 Table 27. Global Flow Cytometry Testing Technology Service Sales Value by Region (%), 2027–2032
 Table 28. Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 29. Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value, (US$ Million), 2021–2026
 Table 30. Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value, (US$ Million), 2027–2032
 Table 31. Bioss Basic Information List
 Table 32. Bioss Description and Business Overview
 Table 33. Bioss Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 34. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Bioss (2021–2026)
 Table 35. Bioss Recent Developments
 Table 36. Q2 Solutions Basic Information List
 Table 37. Q2 Solutions Description and Business Overview
 Table 38. Q2 Solutions Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 39. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Q2 Solutions (2021–2026)
 Table 40. Q2 Solutions Recent Developments
 Table 41. KMD Bioscience Basic Information List
 Table 42. KMD Bioscience Description and Business Overview
 Table 43. KMD Bioscience Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of KMD Bioscience (2021–2026)
 Table 45. KMD Bioscience Recent Developments
 Table 46. Thermo Fisher Scientific Inc Basic Information List
 Table 47. Thermo Fisher Scientific Inc Description and Business Overview
 Table 48. Thermo Fisher Scientific Inc Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Thermo Fisher Scientific Inc (2021–2026)
 Table 50. Thermo Fisher Scientific Inc Recent Developments
 Table 51. BD Basic Information List
 Table 52. BD Description and Business Overview
 Table 53. BD Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of BD (2021–2026)
 Table 55. BD Recent Developments
 Table 56. Creative Bioarray Basic Information List
 Table 57. Creative Bioarray Description and Business Overview
 Table 58. Creative Bioarray Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Creative Bioarray (2021–2026)
 Table 60. Creative Bioarray Recent Developments
 Table 61. Labcorp Basic Information List
 Table 62. Labcorp Description and Business Overview
 Table 63. Labcorp Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Labcorp (2021–2026)
 Table 65. Labcorp Recent Developments
 Table 66. RayBiotech Basic Information List
 Table 67. RayBiotech Description and Business Overview
 Table 68. RayBiotech Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of RayBiotech (2021–2026)
 Table 70. RayBiotech Recent Developments
 Table 71. Sysmex Corporation Basic Information List
 Table 72. Sysmex Corporation Description and Business Overview
 Table 73. Sysmex Corporation Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Sysmex Corporation (2021–2026)
 Table 75. Sysmex Corporation Recent Developments
 Table 76. Abace Biotechnology Basic Information List
 Table 77. Abace Biotechnology Description and Business Overview
 Table 78. Abace Biotechnology Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Abace Biotechnology (2021–2026)
 Table 80. Abace Biotechnology Recent Developments
 Table 81. Multi Sciences (Lianke) Biotech Co., Ltd Basic Information List
 Table 82. Multi Sciences (Lianke) Biotech Co., Ltd Description and Business Overview
 Table 83. Multi Sciences (Lianke) Biotech Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 84. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Multi Sciences (Lianke) Biotech Co., Ltd (2021–2026)
 Table 85. Multi Sciences (Lianke) Biotech Co., Ltd Recent Developments
 Table 86. Shanghai Yingbai Biotechnology Co., Ltd Basic Information List
 Table 87. Shanghai Yingbai Biotechnology Co., Ltd Description and Business Overview
 Table 88. Shanghai Yingbai Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 89. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Shanghai Yingbai Biotechnology Co., Ltd (2021–2026)
 Table 90. Shanghai Yingbai Biotechnology Co., Ltd Recent Developments
 Table 91. COBIOER BIOSCIENCES CO.,LTD Basic Information List
 Table 92. COBIOER BIOSCIENCES CO.,LTD Description and Business Overview
 Table 93. COBIOER BIOSCIENCES CO.,LTD Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 94. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of COBIOER BIOSCIENCES CO.,LTD (2021–2026)
 Table 95. COBIOER BIOSCIENCES CO.,LTD Recent Developments
 Table 96. Shanghai Medicilon Inc Basic Information List
 Table 97. Shanghai Medicilon Inc Description and Business Overview
 Table 98. Shanghai Medicilon Inc Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 99. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Shanghai Medicilon Inc (2021–2026)
 Table 100. Shanghai Medicilon Inc Recent Developments
 Table 101. Beijing Nuowei Biotechnology Co., Ltd Basic Information List
 Table 102. Beijing Nuowei Biotechnology Co., Ltd Description and Business Overview
 Table 103. Beijing Nuowei Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 104. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Beijing Nuowei Biotechnology Co., Ltd (2021–2026)
 Table 105. Beijing Nuowei Biotechnology Co., Ltd Recent Developments
 Table 106. Wuhan Servicebio Technology Co., Ltd Basic Information List
 Table 107. Wuhan Servicebio Technology Co., Ltd Description and Business Overview
 Table 108. Wuhan Servicebio Technology Co., Ltd Flow Cytometry Testing Technology Service Products, Services, and Solutions
 Table 109. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Wuhan Servicebio Technology Co., Ltd (2021–2026)
 Table 110. Wuhan Servicebio Technology Co., Ltd Recent Developments
 Table 111. Revenue (US$ Million) in Flow Cytometry Testing Technology Service Business of Company 40 (2021–2026)
 Table 112. Company 40 Recent Developments
 Table 113. Key Raw Materials Lists
 Table 114. Key Suppliers of Raw Materials Lists
 Table 115. Flow Cytometry Testing Technology Service Downstream Customers
 Table 116. Flow Cytometry Testing Technology Service Distributors List
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources


List of Figures
 Figure 1. Flow Cytometry Testing Technology Service Product Picture
 Figure 2. Global Flow Cytometry Testing Technology Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 4. Flow Cytometry Testing Technology Service Report Years Considered
 Figure 5. Global Flow Cytometry Testing Technology Service Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Flow Cytometry Testing Technology Service Revenue in 2025
 Figure 7. Flow Cytometry Testing Technology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Analytical Picture
 Figure 9. Sorting Type Picture
 Figure 10. Global Flow Cytometry Testing Technology Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Flow Cytometry Testing Technology Service Sales Value Market Share by Type, 2025 & 2032
 Figure 12. Product Picture of Cell Cycle and Apoptosis Analysis
 Figure 13. Product Picture of Immunological Analysis
 Figure 14. Product Picture of Cell Typing Analysis
 Figure 15. Product Picture of Other Fluorescence-Based Cytology Assays
 Figure 16. Global Flow Cytometry Testing Technology Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Flow Cytometry Testing Technology Service Sales Value Market Share by Application, 2025 & 2032
 Figure 18. North America Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 19. North America Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
 Figure 20. Europe Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 21. Europe Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
 Figure 22. Asia Pacific Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 23. Asia Pacific Flow Cytometry Testing Technology Service Sales Value by Subregion (%), 2025 vs 2032
 Figure 24. South America Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 25. South America Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
 Figure 26. Middle East & Africa Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 27. Middle East & Africa Flow Cytometry Testing Technology Service Sales Value by Country (%), 2025 vs 2032
 Figure 28. Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value (%), 2021–2032
 Figure 29. United States Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 30. United States Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 31. United States Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 32. Europe Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 33. Europe Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 34. Europe Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 35. China Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 36. China Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 37. China Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 38. Japan Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 39. Japan Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 40. Japan Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 41. South Korea Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 42. South Korea Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 43. South Korea Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 44. Southeast Asia Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 45. Southeast Asia Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 46. Southeast Asia Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 47. India Flow Cytometry Testing Technology Service Sales Value (US$ Million), 2021–2032
 Figure 48. India Flow Cytometry Testing Technology Service Sales Value by Type (%), 2025 vs 2032
 Figure 49. India Flow Cytometry Testing Technology Service Sales Value by Application (%), 2025 vs 2032
 Figure 50. Flow Cytometry Testing Technology Service Value Chain
 Figure 51. Flow Cytometry Testing Technology Service Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有